EXHIBIT 23.1

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

      We consent to the incorporation by reference in the Registration Statement
(Form S-3) and the related prospectus of Titan Pharmaceuticals, Inc. for the
registration of 933,335 shares of common stock and 417,252 class A warrants of
our report dated February 12, 1999, with respect to the consolidated financial
statements of Titan Pharmaceuticals, Inc. included in its Annual Report (Form
10-K) for the year ended December 31, 1998, filed with the Securities and
Exchange Commission.

Palo Alto, California
October 7, 1999


                                      II-5